A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection-Reference-Cited by-同舟云学术

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

Published:2022-02 Issue:7 Volume:38 Page:110368
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Beaudoin-Bussières Guillaume,Chen Yaozong^ORCID,Ullah Irfan^ORCID,Prévost Jérémie,Tolbert William D.,Symmes Kelly^ORCID,Ding Shilei,Benlarbi Mehdi^ORCID,Gong Shang Yu^ORCID,Tauzin Alexandra^ORCID,Gasser Romain^ORCID,Chatterjee Debashree,Vézina Dani,Goyette Guillaume^ORCID,Richard Jonathan,Zhou Fei,Stamatatos Leonidas^ORCID,McGuire Andrew T.,Charest Hughes,Roger Michel,Pozharski Edwin,Kumar Priti^ORCID,Mothes Walther,Uchil Pradeep D.^ORCID,Pazgier Marzena^ORCID,Finzi Andrés

Funder

FRQS

Canada Foundation for Innovation

Canada Excellence Research Chairs

Mitacs

NIH

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference103 articles.

1. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection;Acharya;J. Virol.,2014

2. COVID-19 severity is associated with differential antibody Fc-mediated innate immune functions;Adeniji;mBio,2021

3. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination;Alter;Res. Sq.,2021

4. The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD;Amanat;medRxiv,2021

5. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells;Amraie;bioRxiv,2020

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1;Journal of Virology;2024-01-23

2. Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2;npj Vaccines;2024-01-20

3. Understanding Fc function for rational vaccine design against pathogens;mBio;2024-01-16

4. Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike;npj Vaccines;2024-01-05

5. Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies;The Journal of Immunology;2023-11-15